Dalvance 500 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FG2PV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,895
Award facts
- Contract value 100% obligated
- $43,894.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $43,894.67 for 500 mg vials of Dalvance, an antibiotic medication commonly used in military and federal healthcare systems. This firm fixed-price contract, awarded on December 22, 2025, with an ultimate completion date of December 23, 2025, represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which extends through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's federal contract portfolio demonstrates extensive experience fulfilling medical procurement requirements across multiple therapeutic domains, positioning it as a critical vendor for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, reflecting the strategic importance of pharmaceutical supply chain management within the defense medical logistics infrastructure.
Quick answers
Who was awarded contract SPE2DR26FG2PV?
SPE2DR26FG2PV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FG2PV worth?
The government has obligated $43,895 on SPE2DR26FG2PV.
Is contract SPE2DR26FG2PV an order under another contract?
Yes. SPE2DR26FG2PV is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG2PV competed?
The extent of competition for SPE2DR26FG2PV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award